Spero Therapeutics, Inc. (FRA:2HA)
Germany · Delayed Price · Currency is EUR 1.978
+0.110 (5.89%)
At close: Nov 28, 2025
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of €110.01 million as of December 1, 2025. Its market cap has increased by 64.31% in one year.
Market Cap
110.01M
Enterprise Value
71.07M
Revenue
34.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.98
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from 137.11M to 110.01M, a decrease of -19.77%. That is a compound annual growth rate of -2.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 110.01M | 102.83% |
| Dec 31, 2024 | 54.24M | -23.05% |
| Dec 29, 2023 | 70.48M | -15.90% |
| Dec 30, 2022 | 83.81M | -81.58% |
| Dec 31, 2021 | 455.04M | 5.59% |
| Dec 31, 2020 | 430.96M | 162.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 2, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |